Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose

NCT01465243 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Icotinib

Sponsor

Betta Pharmaceuticals Co., Ltd.